Please assess the completion status of the following clinical trial:

Trial Title: Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pathologically confirmed diagnosis of non-anaplastic non-medullary thyroid cancer that is either grossly recurrent after surgery or unresectable with or without metastatic disease.~* Age ≥18 years~* Karnofsky performance status ≥70%~* Men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months after treatment.~* Patients must have ability to understand and the willingness to sign a written informed consent document.~Exclusion Criteria:~* Women who are pregnant or lactating~* Inability to comply with study and/or follow-up procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IMRT and doxorubicin (Type: EXPERIMENTAL): All patients will undergo radiation treatments using IMRT with concurrent low-dose radiosensitizing doxorubicin at 10 mg/m2 will be administered.

Based on this trial design, predict the completion outcome and termination type (if applicable).